RT Journal Article
SR Electronic
T1 Predicting outcomes of cross-sex hormone therapy in gender dysphoria based on pre-therapy resting-state brain connectivity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.11.20147538
DO 10.1101/2020.07.11.20147538
A1 Teena D Moody
A1 Jamie D Feusner
A1 Nicco Reggente
A1 Jonathan Vanhoecke
A1 Mats Holmberg
A1 Amirhossein Manzouri
A1 Behzad Sorouri Khorashad
A1 Ivanka Savic
YR 2020
UL http://medrxiv.org/content/early/2020/07/21/2020.07.11.20147538.abstract
AB Individuals with gender dysphoria experience serious distress due to incongruence between their gender identity and birth-assigned sex. Sociological, cultural, interpersonal, and biological factors are likely contributory, and for some individuals medical treatment such as cross-hormone therapy and gender affirming surgery can be helpful. Cross-hormone therapy can be effective for reducing body incongruence, but responses vary, and there is no reliable way to predict therapeutic outcomes. We used clinical and MRI data before cross-sex hormone therapy as features to train a machine learning model to predict individuals’ post-therapy body congruence (the degree to which photos of their bodies match their self-identities). Twenty-five trans women and trans men with gender dysphoria participated. The model significantly predicted post-therapy body congruence, with the highest predictive features coming from the fronto-parietal and cingulo-opercular networks. This study provides evidence that hormone therapy efficacy can be predicted from information collected before therapy and that patterns of functional brain connectivity may provide insights into body-brain effects of hormones, affecting one’s sense of body congruence. Results could help identify the need for personalized therapies in individuals predicted to have low body-self congruence after standard therapy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Swedish Science Council (Dnr 200 7-3107 to I.S) and the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (1R01HD087712 to I.S. and J.F.). J.V. was supported by the Vocatio Foundation (Belgium).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All participants provided full informed consent in accordance with the Karolinska Institute ethical committee (Application # Dnr 2011/281-31/4).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData availability is governed by the Swedish IRB.